Document is current
Any future updates will be listed below
-
Authors
Terstappen, Jonne
Nibbelke, Elisabeth E.
Ascough, Stephanie
Bergstrom, Emma
Bont, Louis J.
Buiteman, Brigitte J. M.
Chiu, Chris
Cianci, Daniela
Dayananda, Pete
Delemarre, Eveline M.
de Groot-Mijnes, Jolanda D. F.
McCall, Matthew B. B.
Reitsma, Johannes B.
Schuurman, Rob
Taylor, Lydia
Troelstra, Annet
Versnel, Anouk
Vlaskamp, Jacqueline
Viveen, Marco
van Zoggel, Hanneke J.A.A.
Mazur, Natalie I.
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 4 June 2025
First Online: 3 July 2025
Competing interests
: JT and NIM have received support for attending meetings and/or travel from the ResViNET Foundation. UMC Utrecht has received grants from AbbVie, AstraZeneca, The Bill & Melinda Gates Foundation, the Dutch Lung Foundation, The Gates Medical Research Institute, GSK, Janssen, MedImmune, MeMed, Merck, Novavax, Pfizer, and Sanofi; has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AbbVie, Ablynx, Astrazeneca, Bavaria Nordic, GSK, Janssen, MabXience, MedImmune, MEDtalks, Merck, Moderna, Novavax, Pfizer, Sanofi and Virology Education. LB is founding chairman of the ReSViNET Foundation. All other authors declare no financial or non-financial competing interests.
